<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gibbons C</submitter><funding>Horizon 2020 Framework Programme</funding><funding>Steno Diabetes Center Copenhagen (SDCC)</funding><funding>American Beverage Association</funding><funding>Horizon 2020</funding><pagination>105005</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11026940</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>102</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Sweeteners and sweetness enhancers (S&amp;SE) are used to replace energy yielding sugars and maintain sweet taste in a wide range of products, but controversy exists about their effects on appetite and endocrine responses in reduced or no added sugar solid foods. The aim of the current study was to evaluate the acute (1 day) and repeated (two-week daily) ingestive effects of 2 S&amp;SE vs. sucrose formulations of biscuit with fruit filling on appetite and endocrine responses in adults with overweight and obesity.&lt;h4>Methods&lt;/h4>In a randomised crossover trial, 53 healthy adults (33 female, 20 male) with overweight/obesity in England and France consumed biscuits with fruit filling containing 1) sucrose, or reformulated with either 2) Stevia Rebaudioside M (StRebM) or 3) Neotame d</pubmed_abstract><journal>EBioMedicine</journal><pubmed_title>Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity-a randomised crossover trial from the SWEET consortium.</pubmed_title><pmcid>PMC11026940</pmcid><funding_grant_id>774293</funding_grant_id><funding_grant_id>SDCC 3.F CMP</funding_grant_id><pubmed_authors>Kjolbæk L</pubmed_authors><pubmed_authors>Raben A</pubmed_authors><pubmed_authors>Scott C</pubmed_authors><pubmed_authors>Harrold JA</pubmed_authors><pubmed_authors>Rannou C</pubmed_authors><pubmed_authors>Martinez JA</pubmed_authors><pubmed_authors>Finlayson G</pubmed_authors><pubmed_authors>Wilton M</pubmed_authors><pubmed_authors>Beaulieu K</pubmed_authors><pubmed_authors>Navas-Carretero S</pubmed_authors><pubmed_authors>Moshoyiannis H</pubmed_authors><pubmed_authors>Nazare JA</pubmed_authors><pubmed_authors>Halford JCG</pubmed_authors><pubmed_authors>Gibbons C</pubmed_authors><pubmed_authors>O'Hara B</pubmed_authors><pubmed_authors>O'Connor D</pubmed_authors><pubmed_authors>Hardman C</pubmed_authors><pubmed_authors>Le Bail A</pubmed_authors><pubmed_authors>Almiron-Roig E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity-a randomised crossover trial from the SWEET consortium.</name><description>&lt;h4>Background&lt;/h4>Sweeteners and sweetness enhancers (S&amp;SE) are used to replace energy yielding sugars and maintain sweet taste in a wide range of products, but controversy exists about their effects on appetite and endocrine responses in reduced or no added sugar solid foods. The aim of the current study was to evaluate the acute (1 day) and repeated (two-week daily) ingestive effects of 2 S&amp;SE vs. sucrose formulations of biscuit with fruit filling on appetite and endocrine responses in adults with overweight and obesity.&lt;h4>Methods&lt;/h4>In a randomised crossover trial, 53 healthy adults (33 female, 20 male) with overweight/obesity in England and France consumed biscuits with fruit filling containing 1) sucrose, or reformulated with either 2) Stevia Rebaudioside M (StRebM) or 3) Neotame d</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-01T09:19:45.953Z</modification><creation>2026-04-08T11:03:19.913Z</creation></dates><accession>S-EPMC11026940</accession><cross_references><pubmed>38553262</pubmed><doi>10.1016/j.ebiom.2024.105005</doi></cross_references></HashMap>